Company & Sponsor Intelligence
University Hospital, Bonn
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed2
Countries1
Therapeutic footprint
epilepsyother_neurologyschizophrenia
Indexed studies
NCT00545493Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis
epilepsy · GermanyPHASE2, PHASE3
epilepsy · GermanyPHASE2, PHASE3
NCT05320991Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers
schizophrenia · GermanyPHASE4
schizophrenia · GermanyPHASE4
NCT01318018Investigation on the Value of Bilateral Index (BIS) Monitoring for Magnetic Seizure Versus Electroconvulsive Therapy
epilepsy · GermanyCOMPLETED
epilepsy · GermanyCOMPLETED
NCT04137432Oxytocin-augmented Cognitive-behavioral Group-based Short-term Intervention for Loneliness
other_neurology · GermanyPHASE1
other_neurology · GermanyPHASE1
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →